Grafa News and Videos — Page 129

Data centre developer Firmus is targeting an initial public offering on Oct. 22 that could value the business at up to US$60 billion.

Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) received authorization from Health Canada for their Omicron XFG-adapted COVID-19 vaccine.

Intuit (NASDAQ:INTU) provided fiscal 2027 guidance, expecting full-year revenue of $23.28 billion to $23.51 billion and first-quarter revenue of $4.29 billion to $4.31 billion.

Surgery Partners (NASDAQ:SGRY) updated its 2026 financial outlook following the completed sale of its Idaho Falls facilities to Intermountain Health.

Olenox Industries (NASDAQ:OLOX) reported that its CS Digital Ventures operations mined approximately 15.63 Bitcoin in August 2026 as the company continued operating its digital asset mining infrastructure.

MIRA Pharmaceuticals (NASDAQ:MIRA) submitted a Phase 2a clinical trial protocol for Ketamir-2 in chemotherapy-induced peripheral neuropathy (CIPN) following review and feedback from the U.S. Food and Drug Administration.

Applied Materials (NASDAQ:AMAT) announced plans to invest $5 billion in India over the next decade as the semiconductor equipment maker expands its presence in the country.

Atlanticus Holdings (NASDAQ:ATLC) completed the sale of its CAR Auto Finance operations for approximately $71.2 million, ending the company’s Auto Finance segment.

AtlasClear Holdings (NYSE:ATCH) expects preliminary fiscal 2026 revenue of approximately $20.1 million, up about 85% from $10.9 million in fiscal 2025, according to an update from the company.

Clearmind Medicine (NASDAQ:CMND) reported that its Chief of Global Impact Mary-Elizabeth Gifford participated in a U.S. Food and Drug Administration panel focused on potential future therapeutic use of psychedelic drugs.